Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities

PURPOSE: The standard treatment for locally advanced cervical cancer (LACC) is concomitant chemoradiotherapy with cisplatin (CDDP) followed by brachytherapy. The presence of comorbidities are risk factors for nephrotoxicity and are associated with lower survival. Gemcitabine is a radiosensitizing dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Brau-Figueroa, Hasan, Arango-Bravo, Eder, Castro-Eguiluz, Denisse, Galicia-Carmona, Tatiana, Lugo-Alferez, Leopoldo Abraham, Cruz-Bautista, Ivette, Jiménez-Lima, Roberto, Cetina-Pérez, Lucely
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016315/
https://www.ncbi.nlm.nih.gov/pubmed/34384015
http://dx.doi.org/10.4143/crt.2021.375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016315/
https://www.ncbi.nlm.nih.gov/pubmed/34384015
http://dx.doi.org/10.4143/crt.2021.375

Ejemplares similares